"CLAVSAT-625 tablets combine Amoxicillin and Potassium Clavulanate to treat bacterial infections effectively. Amoxicillin, a penicillin antibiotic, inhibits bacterial cell wall synthesis. Potassium Clavulanate enhances Amoxicillin's activity by inhibiting beta-lactamase enzymes that can render Amoxicillin ineffective. This combination is prescribed for moderate to severe infections such as respiratory tract infections, urinary tract infections, and skin infections, ensuring comprehensive bacterial eradication and reducing the likelihood of antibiotic resistance.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations "